Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-erythropoietin antibodies and pure red cell aplasia.

Literature DB >> 14747386

Anti-erythropoietin antibodies and pure red cell aplasia.

Jerome Rossert¹, Nicole Casadevall, Kai-Uwe Eckardt.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2004 PMID： 14747386 DOI： 10.1097/01.asn.0000107561.59698.42

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

Keyword Cloud
Cited

× No keyword cloud information.

27 in total

1. A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.

Authors: Holly M Koncicki; Steven Fishbane
Journal: Clin J Am Soc Nephrol Date: 2017-05-18 Impact factor: 8.237

2. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

Authors: Charles L Bennett; Denis Cournoyer; Kenneth R Carson; Jerome Rossert; Stefano Luminari; Andrew M Evens; Francesco Locatelli; Steven M Belknap; June M McKoy; E Alison Lyons; Benjamin Kim; Rishi Sharma; Stacey Costello; Edwin B Toffelmire; George A Wells; Hans A Messner; Paul R Yarnold; Steven M Trifilio; Dennis W Raisch; Timothy M Kuzel; Allen Nissenson; Lay-Cheng Lim; Martin S Tallman; Nicole Casadevall
Journal: Blood Date: 2005-08-11 Impact factor: 22.113

Review 3. Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors: Lorraine C Pelosof; David E Gerber
Journal: Mayo Clin Proc Date: 2010-09 Impact factor: 7.616

4. Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.

Authors: Melita Buljan; Damir Nemet; Branka Golubic-Cepulic; Goran Bicanic; Branko Tripkovic; Domagoj Delimar
Journal: Int Orthop Date: 2011-10-01 Impact factor: 3.075

5. 2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions.

Authors: Jonathan Bones; Niaobh McLoughlin; Mark Hilliard; Kieran Wynne; Barry L Karger; Pauline M Rudd
Journal: Anal Chem Date: 2011-05-02 Impact factor: 6.986

Anti-erythropoietin antibodies and pure red cell aplasia.

1. A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.

2. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

Review 3. Paraneoplastic syndromes: an approach to diagnosis and treatment.

4. Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.

5. 2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions.

Review 6. Use of agents stimulating erythropoiesis in digestive diseases.

Review 7. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

8. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone.

9. Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.

10. [Renal anemia - an important secondary disease in renal insufficiency].